Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed.
about
Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed.
@en
Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed.
@nl
type
label
Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed.
@en
Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed.
@nl
prefLabel
Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed.
@en
Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed.
@nl
P2093
P2860
P1433
P1476
Long-Acting β2-Agonists in Asthma: Enantioselective Safety Studies are Needed.
@en
P2093
Clive P Page
E Haydn Walters
Glenn A Jacobson
Luigino Calzetta
Mark O Farber
Richard Wood-Baker
P2860
P2888
P356
10.1007/S40264-017-0631-1
P577
2018-01-13T00:00:00Z